CLINICAL_TRIALS
trial_result
· 2023-09-01
Clinical Trial Update: Safety and Efficacy of BIA 5-1058 in PAH [Phase 2]
Summary
Phase 2 trial results for BIA 5-1058 in pulmonary arterial hypertension have been completed, reporting safety and efficacy outcomes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED